These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2116580)

  • 1. Principles involved in costing.
    Evans DB
    Med J Aust; 1990 Aug; 153(S1):S10-2. PubMed ID: 2116580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What every doctor should know about economics. Part 1. The benefits of costing.
    Hall J; Mooney G
    Med J Aust; 1990 Jan; 152(1):29-31. PubMed ID: 2104645
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic assessments in randomized controlled trials.
    Bulpitt CJ; Fletcher AE
    Med J Aust; 1990 Aug; 153(S1):S16-9. PubMed ID: 2116582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct costs of stroke for a Swedish population.
    Persson U; Silverberg R; Lindgren B; Norrving B; Jadbäck G; Johansson B; Puranen BI
    Int J Technol Assess Health Care; 1990; 6(1):125-37. PubMed ID: 2113889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costing interventions in primary care.
    Kernick D
    Fam Pract; 2000 Feb; 17(1):66-70. PubMed ID: 10673493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of stroke.
    Forbes JF
    Scott Med J; 1993 Jun; 38(3 Suppl):S4-5. PubMed ID: 8356437
    [No Abstract]   [Full Text] [Related]  

  • 7. Costs of stroke using patient-level data: a critical review of the literature.
    Luengo-Fernandez R; Gray AM; Rothwell PM
    Stroke; 2009 Feb; 40(2):e18-23. PubMed ID: 19109540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The state of the art of costing health care for economic evaluation.
    Donaldson C
    Community Health Stud; 1990; 14(4):341-56. PubMed ID: 2127388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of stroke and its sequelae.
    Christie D
    Med J Aust; 1981 Aug; 2(4):182-4. PubMed ID: 6457966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of stroke in Sweden. A national perspective.
    Terént A; Marké LA; Asplund K; Norrving B; Jonsson E; Wester PO
    Stroke; 1994 Dec; 25(12):2363-9. PubMed ID: 7974574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lives Saved Tool (LiST) costing: a module to examine costs and prioritize interventions.
    Bollinger LA; Sanders R; Winfrey W; Adesina A
    BMC Public Health; 2017 Nov; 17(Suppl 4):782. PubMed ID: 29143622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP).
    Thorn JC; Turner EL; Hounsome L; Walsh E; Down L; Verne J; Donovan JL; Neal DE; Hamdy FC; Martin RM; Noble SM;
    BMJ Open; 2016 Apr; 6(4):e011063. PubMed ID: 27130167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic costs of stroke in Massachusetts.
    Mills E; Thompson M
    N Engl J Med; 1978 Aug; 299(8):415-8. PubMed ID: 672940
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebrovascular epidemiology - Economic factors.
    Goldstein M
    J Neuroradiol; 1983; 10(2):160-4. PubMed ID: 6875671
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study.
    Tung CY; Granger CB; Sloan MA; Topol EJ; Knight JD; Weaver WD; Mahaffey KW; White H; Clapp-Channing N; Simoons ML; Gore JM; Califf RM; Mark DB
    Circulation; 1999 Jan; 99(3):370-6. PubMed ID: 9918523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic implications of treating atherothrombotic disease in Australia, from the government perspective.
    Ademi Z; Liew D; Hollingsworth B; Wolfe R; Steg GP; Bhatt DL; Reid CM;
    Clin Ther; 2010 Jan; 32(1):119-32; discussion 106-7. PubMed ID: 20171418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Costs of stroke care. Lower costs in spite of increased incidence].
    Terént A
    Lakartidningen; 1993 Aug; 90(34):2758-63. PubMed ID: 8366712
    [No Abstract]   [Full Text] [Related]  

  • 19. Costs of medical care after first-ever stroke in The Netherlands.
    Bergman L; van der Meulen JH; Limburg M; Habbema JD
    Stroke; 1995 Oct; 26(10):1830-6. PubMed ID: 7570734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-Driven Activity-Based Costing in Urologic Surgery Cycles of Care.
    McClintock TR; Shah MA; Chang SL; Haleblian GE
    Value Health; 2019 Jul; 22(7):768-771. PubMed ID: 31277822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.